Ajanta's artemether/lumefantrine tablet range prequalified
M
WHO Prequalification Team - Medicines (PQT) added the below new products to its prequalified list
WHO Prequalification Team - Medicines (PQT) added the below new products to its prequalified list
WHO Prequalification Team - Medicines (PQT) added the below new products to its prequalified list
WHO Prequalification Team - Medicines (PQT) added the below new products to its prequalified list
On 31 March 2017, WHO for the first time prequalified a generic active pharmaceutical ingredient (API) for hepatitis C – sofosbuvir.
The following products were added: